Patient-Derived In Vitro Models of Ovarian Cancer: Powerful Tools to Explore the Biology of the Disease and Develop Personalized Treatments
Epithelial ovarian cancer (OC) is the most lethal gynecological malignancy worldwide due to a late diagnosis caused by the lack of specific symptoms and rapid dissemination into the peritoneal cavity. The standard of care for OC treatment is surgical cytoreduction followed by platinum-based chemothe...
Main Authors: | Chiara Battistini, Ugo Cavallaro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/2/368 |
Similar Items
-
Current Status of Patient-Derived Ovarian Cancer Models
by: Yoshiaki Maru, et al.
Published: (2019-05-01) -
Patient‐derived organoid culture in epithelial ovarian cancers—Techniques, applications, and future perspectives
by: Wai Sun Chan, et al.
Published: (2023-10-01) -
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells
by: Takeshi Namekawa, et al.
Published: (2019-01-01) -
Exploring the Potential of Drug Response Assays for Precision Medicine in Ovarian Cancer
by: Tanya Singh, et al.
Published: (2020-12-01) -
Insights into high-grade serous carcinoma pathobiology using three-dimensional culture model systems
by: Emily Tomas, et al.
Published: (2023-04-01)